Baiji Shen Zhou (06160.HK) appoints Wang Lai, global head of research and development, as the company's president and global head of research and development.

Intelligence Finance News APP, BeiGene (06160.HK) announced that on December 17, 2025, after being reviewed and approved by the board of directors of BeiGene Limited (hereinafter referred to as the "Company"), the board of directors agreed to appoint Dr. Wang Lai, the global head of research and development of the Company, as the President and global head of research and development of the Company. After the appointment takes effect, Dr. Wang Lai will be responsible for managing the Company's research and development, business expansion, and business alliance relationship management.